首页> 外文期刊>Domestic Animal Endocrinology >Low-density lipoprotein-related receptor protein 1 (LRP-1) is not required for insulin-like growth factor binding protein 3 (IGFBP-3) to suppress L6 myogenic cell proliferation
【24h】

Low-density lipoprotein-related receptor protein 1 (LRP-1) is not required for insulin-like growth factor binding protein 3 (IGFBP-3) to suppress L6 myogenic cell proliferation

机译:胰岛素样生长因子结合蛋白3(IGFBP-3)抑制L6成肌细胞增殖不需要低密度脂蛋白相关受体蛋白1(LRP-1)

获取原文
获取原文并翻译 | 示例
       

摘要

Insulin-like growth factor binding protein-3 (IGFBP-3) suppresses proliferation of numerous cell types, including myogenic cells, via both insulin-like growth factor (IGF) dependent and IGF-independent mechanisms; however, the mechanism of IGF-independent suppression of proliferation is not clearly defined. In nonmuscle cells, binding of IGFBP-3 to the low-density lipoprotein receptor-related protein-1 (LRP-1)/activated alpha M-2 receptor is reportedly required for IGFBP-3 to inhibit proliferation. These findings suggest that binding to this receptor also may be required for IGFBP-3 to suppress proliferation of cultured myogenic cells. To investigate the role of the LRP-1 receptor in suppression of myogenic cell proliferation by IGFBP-3, we have examined the effect of receptor-associated protein, an LRP-1 receptor antagonist, on recombinant porcine (rp)IGFBP-3 inhibition of L6 myogenic cell proliferation. Treatment with receptor-associated protein results in a 37% decrease (P < 0.05) in the ability of rpIGFBP-3 to inhibit L6-cell proliferation. In L6 cells subjected to LRP-1 small interfering RNA treatment for 48 h (LRP-1 silenced), LRP-1 mRNA levels were reduced by greater than 80% compared with control cultures treated with nonsense small interfering RNA (mock silenced). In addition, the 85-kDa transmembrane subunit of LRP-1 was undetectable in Western immunoblots of total protein lysates from LRP-1-silenced cells. Even though LRP-1 mRNA and protein levels were dramatically reduced in LRP-1 silenced L6 cells compared with mock-silenced controls, rpIGFPB-3 suppressed proliferation rate to the same extent in both LRP-1 silenced and mock-silenced cultures. Our results strongly suggest that, in contrast to data obtained for nonmuscle cell lines, the LRP-1 receptor is not required for IGFBP-3 to suppress proliferation of L6 myogenic cells
机译:胰岛素样生长因子结合蛋白3(IGFBP-3)通过胰岛素样生长因子(IGF)依赖性和IGF依赖性机制抑制多种细胞类型(包括成肌细胞)的增殖;但是,尚不清楚IGF依赖性增殖抑制的机制。在非肌肉细胞中,据报道,IGFBP-3与低密度脂蛋白受体相关蛋白1(LRP-1)/活化的αM-2受体结合需要IGFBP-3抑制增殖。这些发现表明,IGFBP-3抑制培养的成肌细胞的增殖也可能需要与该受体结合。为了研究LRP-1受体在IGFBP-3抑制肌原细胞增殖中的作用,我们研究了受体相关蛋白LRP-1受体拮抗剂对重组猪(rp)IGFBP-3的抑制作用。 L6成肌细胞增殖。用受体相关蛋白治疗导致rpIGFBP-3抑制L6细胞增殖的能力降低了37%(P <0.05)。在经过LRP-1小干扰RNA处理48小时(LRP-1沉默)的L6细胞中,与用无意义小干扰RNA(模拟沉默)处理的对照培养物相比,LRP-1 mRNA水平降低了80%以上。另外,在来自LRP-1沉默的细胞的总蛋白裂解物的Western免疫印迹中无法检测到LRP-1的85kDa跨膜亚基。尽管与模拟沉默的对照组相比,LRP-1沉默的L6细胞中LRP-1 mRNA和蛋白水平显着降低,但是rpIGFPB-3在LRP-1沉默和模拟沉默的培养物中均以相同程度抑制了增殖速率。我们的结果强烈表明,与从非肌肉细胞系获得的数据相比,IGFBP-3不需要LRP-1受体来抑制L6成肌细胞的增殖

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号